Skip to main content
SpringerLink
Log in

Pharmacokinetics in Patients with Cardiac Failure

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Cardiac failure is often associated with disturbances in cardiac output, autonomic nervous system activity, central and systemic venous pressures, and sodium and water metabolism. These disturbances influence the extent and pattern of tissue perfusion, may lead to tissue hypoxia and visceral congestion, and may alter gastrointestinal motility. By these mechanisms, cardiac failure potentially affects absorption and disposition characteristics of drugs, which may necessitate adjustment in dosage regimen for optimum therapy.

Lignocaine is the drug which has been studied most extensively in cardiac failure. Volumes of distribution and clearance are decreased. As a drug whose metabolism is largely limited by liver blood flow, decreased blood flow to the liver accounts for some of the change in clearance, but impaired hepatic metabolism appears also to play a role in some patients. Accumulation of active metabolites of lignocaine and procainamide in patients with cardiac failure can influence therapeutic and toxic effects. Theophylline metabolism, which is largely independent of blood flow, appears to be reduced significantly in patients with severe cardiac failure and necessitates reduction of dosage. In the presence of severe cardiac failure, digoxin clearance may be less than anticipated on the basis of estimates of renal function. Quinidine plasma levels may be higher after single doses due to reduced volume of distribution. Quinidine metabolites are believed not to be pharmacologically active but may create confusion with nonspecific assays. Specific assays are recommended in cardiac failure, especially complicated by renal insufficiency.

Data are lacking relating pharmacokinetic alterations to haemodynamic measurements in patients with cardiac failure. Whereas the direction of change in pharmacokinetic parameters may be predicted, variability in the magnitude of change is so great that determination of drug concentration in blood remains an essential adjunct to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson, K.V.; Brettel, H.R. and Aikawa, J.K.: C14-labeled hydrochlorothiazide in human beings. Archives of Internal Medicine 107: 168–174 (1961).

    Google Scholar 

  • Barger, A.C.: Renal hemodynamic factors in congestive heart failure. Annals of the New York Academy of Sciences 39: 276–284 (1966).

    Article  Google Scholar 

  • Bates, T.R. and Gibaldi, M.: Gastrointestinal absorption of drugs; in Swarbrick (Ed) Current Concepts in Pharmaceutical Sciences: Biopharmaceutics, p. 57–99 (Lea and Febiger, Philadelphia 1970).

    Google Scholar 

  • Bellet, S.; Roman, L.R. and Boza, À.: Relation between serum quinidine levels and renal function. Studies in normal subjects and patients with congestive failure and renal insufficiency. American Journal of Cardiology 27: 368–371 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Benet, L.Z.: Biopharmaceutics as a basis for the design of drug products; in Ariens (Ed) Drug Design, Vol IV, p.1–35 (Academic Press, New York 1973).

    Google Scholar 

  • Benet, L.Z.; Greither, A. and Meister, W.: Gastrointestinal absorption of drugs in patients with cardiac failure; in Benet (Ed) The Effect of Disease States on Pharmacokinetics, p.33–50 (American Pharmaceutical Association, Washington 1976).

    Google Scholar 

  • Bennett, W.M.: Principles of drug therapy in patients with renal disease. Western Journal of Medicine 123: 372–379 (1975).

    PubMed  CAS  Google Scholar 

  • Benowitz, N.L.: Clinical applications of the pharmacokinetics of lidocaine; in Melmon (Ed) Cardiovascular Drug Therapy, p.77–101 (Davis, Philadelphia 1974).

    Google Scholar 

  • Benowitz, N.; Forsyth, R.P.; Melmon, K.L. and Rowland, M.: Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clinical Pharmacology and Therapeutics 16: 87–98 (1974a).

    PubMed  CAS  Google Scholar 

  • Benowitz, N.; Forsyth, R.P.; Melmon, K.L. and Rowland, M.: Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration. Clinical Pharmacology and Therapeutics 16: 99–109 (1974b).

    PubMed  CAS  Google Scholar 

  • Berkowitz, D.; Droll, M.N. and Likoff, W.: Malabsorption as a complication of congestive heart failure. American Journal of Cardiology 11: 43–47 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Beubler, E. and Lembeck, F.: Methylxanthines and intestinal drug absorption. Nauny-Schmiedeberg’s Archives of Pharmacology 292: 73–77 (1976).

    Article  CAS  Google Scholar 

  • Branch, R.A.; Shand, D.G.; Wilkinson, G.R. and Nies, A.S.: The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. Journal of Pharmacology and Experimental Therapeutics 184: 515–519 (1973).

    PubMed  CAS  Google Scholar 

  • Braunwald, E.; Ross, J., Jr. and Sonnenblick, E.H.: Mechanisms of Contraction of the Normal and Failing Heart, 2nd ed, p.309–356 (Little, Brown, Boston 1976).

    Google Scholar 

  • Burchell, H.B.: Editorial: Purging action of qunidine. Potentiation of contraction coupling to basic electric rhythms. Circulation 36: 173–174 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Collinsworth, K.A.; Kaiman, S.M. and Harrison, D.C.: The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation 50: 1217–1230 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Crooks, J.; O’Malley, K. and Stevenson, I.H.: Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Crouthamel, W.G.; Diamond, L.; Dittert, L.W. and Doluisio, J.T.: Drug absorption. VII. Influence of mesenteric blood flow on intestinal drug absorption in dogs. Journal of Pharmaceutical Sciences 64: 661–671 (1975).

    Google Scholar 

  • Cumming, J.F. and Mannering, G.J.: Effect of phenobarbital administration on the oxygen requirement for hexobarbital metabolism in the isolated, perfused rat liver and in the intact rat. Biochemical Pharmacology 19: 973–978 (1970).

    Article  CAS  Google Scholar 

  • Dettli, L.: Drug dosage in renal disease. Clinical Pharmacokinetics 1: 126–134 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Ditlefsen, E.-M.L.: Quinidine concentration in blood and excretion in urine following parenteral administration as related to congestive heart failure. Acta Medica Scandinavica 159: 105–109 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Dobbs, S.M.; Mawer, G.E.; Rodger, E.M.; Woodlock, B.G. and Lucas, S.B.: Can digoxin dose requirements be predicted? British Journal of Clinical Pharmacology 3: 231–237 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Doherty, J.E. and Perkins, W.H.: Studies with tritiated digoxin in human subjects after intravenous administration. American Heart Journal 63: 528–536 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Doherty, J.E.; Perkins, W.H. and Mitchell, G.K.; Tritiated digoxin. Studies in human subjects. Archives of Internal Medicine 108: 531–539 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Dunn, G.D.; Hayes, P.; Breen, K.J. and Schenker, S.: The liver in congestive heart failure: A review. American Journal of the Medical Sciences 265: 174–189 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Eckberg, D.L.; Drabinsky, M. and Braunwald, E.: Defective cardiac parasympathetic control in patients with heart disease. New England Journal of Medicine 285: 877–883 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Editorial Bioavailability after intramuscular injection. Lancet 1: 261 (1975).

  • Elson, J.; Strong, J.M.; Lee, W.-K. and Atkinson, A.J.; Jr.: Antiarrhythmic potency of N-acetylprocainamide. Clinical Pharmacology and Therapeutics 17: 134–140 (1975).

    PubMed  CAS  Google Scholar 

  • Evans, E.F.; Proctor, J.D.; Fratkin, M.J.; Velandia, J. and Wasserman, A.J.: Blood flow in muscle groups and drug absorption. Clinical Pharmacology and Therapeutics 17: 44–47 (1975).

    PubMed  CAS  Google Scholar 

  • Fabre, J. and Balant, L.: Renal failure, drug pharmacokinetics and drug action. Clinical Pharmacokinetics 1: 99–120 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Galeazzi, R.L.; Sheiner, L.B.; Lockwood, T. and Benet, L.Z.: The renal elimination of procainamide. Clinical Pharmacology and Therapeutics 19: 55–62 (1976).

    PubMed  CAS  Google Scholar 

  • Gibaldi, M. and Perrier, M.: Route of administration and drug disposition. Drug Metabolism Reviews 3: 185–199 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Gibson, T.P.; Matusik, E.J. and Briggs, W.A.: N-acetylprocainamide levels in patients with end-stage renal failure. Clinical Pharmacology and-Therapeutics 19: 206–212 (1976).

    PubMed  CAS  Google Scholar 

  • Greenblatt, D.J; Duhme, D.J.; Koch-Weser, J. and Smith, T.W.: Evaluation of digoxin bioavailability in single-dose studies. New England Journal of medicine 289: 651–654 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt, D.J. and Koch-Weser, J.: Drug therapy: intramuscular injection of drugs. New England Journal of Medicine 295: 542–546 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Greither, A.; Goldman, S.; Edelen, J.S.; Conn, K. and Benet, L.Z.: Erratic and incomplete absorption of furosemide in congestive heart failure. American Journal of Cardiology 37: 139 (1976).

    Article  Google Scholar 

  • Haass, A.; Liillmann, H. and Peters, T.: Absorption rates of some cardiac glycosides and portal blood flow. European Journal of Pharmacology 19: 336–370 (1972).

    Article  Google Scholar 

  • Halkin, H.; Meffin, P.; Melmon, K.L. and Rowland, M.: Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite. Clinical Pharmacology and Therapeutics 17: 669–676 (1975a).

    PubMed  CAS  Google Scholar 

  • Halkin, H.; Sheiner, LB.; Peck, C.C. and Melmon, K.L.: Determinants of the renal clearance of digoxin. Clinical Pharmacology and Therapeutics 17: 385–394 (1975b).

    PubMed  CAS  Google Scholar 

  • Hillestad, L.; Hansen, T.; Melsom, H. and Drivenes, A.: Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clinical Pharmacology and Therapeutics 16: 479–484 (1974).

    PubMed  CAS  Google Scholar 

  • Hirschfeld, D.S.; Ueda, CT.; Rowland, M. and Scheinman, M.M.: Clinical and elctrophysiological effects of intravenous quinidine in man. British Heart Journal (in press).

  • Huffman, D.H.; Crow, J.W.; Pentikäinen, P. and Azarnoff, D.L.; Association between clinical cardiac status, laboratory parameters, and digoxin usage. American Heart Journal 91: 28–34 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Jenne, J.W.; Chick, T.W.; Miller, B.A. and Strickland, R.D.: Effect of congestive heart failure on the elimination of theophylline. Journal of Allergy and Clinical Immunology 53: 80 (1974).

    Google Scholar 

  • Jonkman, J.H.G.; Van Brok, L.E.; De Zeeuw, R.A. and Orie, N.G.M.: Bioavailability after intramuscular injection. Lancet 1: 693 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Jusko, W.J.; Koup, J.J.; Schentag, J.J. and Vance, J.W.: Surveillance of factors affecting theophylline clearances in patients. Program of the 123rd Annual Meeting of the American Pharmaceutical Association, New Orleans, p. 145 (1976).

    Google Scholar 

  • Kessler, K.M.; Lowenthal, D.T.; Warner, H.; Gibson, T.; Briggs, W. and Reidenberg, M.M.: Quinidine elimination in patients with congestive heart failure or poor renal function. New England Journal of medicine 290: 706–709 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser, J.: Pharmacokinetics of procainamide in man. Annals of the New York Academy of Science 179: 370–382 (1971).

    Article  CAS  Google Scholar 

  • Koch-Weser, J. and Klein, S.W.: Procainamide dosage schedules, plasma concentrations, and clinical effects. Journal of the American Medical Association 215: 1454–1460 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Lloyd, B.L. and Taylor, R.R.: Augmentation of myocardial digoxin concentration in hemorrhagic shock. Circulation 51: 718–722 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Manninen, V.; Apajalahti, A.; Melin, J. and Karesoja, M. Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet 1: 398–401 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Marcus, F.I.; Kapadia, G.J. and Kapadia, G.G.: The metabolism of digoxin in normal subjects. Journal of Pharmacology and Experimental Therapeutics 145: 203–209 (1964).

    PubMed  CAS  Google Scholar 

  • Myers, J.D. and Hickam, J.B.: Estimation of hepati blood flow and splanchnic oxygen consumption in heart failure. Journal of Clinical Investigation 27: 620–627 (1948).

    Article  PubMed  CAS  Google Scholar 

  • Nies, A.S.; Evans, G.H. and Shand, D.G.: The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. Journal of Pharmacology and Experimental Therapeutics 184: 716–720 (1973).

    PubMed  CAS  Google Scholar 

  • Nies, A.S.; Shand, D.G. and Wilkinson, G.R.: Altered hepatic blood flow and drug disposition. Clinical Pharmacokinetics 1: 135–155 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Ohnhaus, E.E.; Vozeh, S. and Nüesch, E.: Untersuchungen zur Resorption von Digoxin bei Patienten mit dekompensierter Rechtsherzinsuffizienz. Schweizerische Medizinische Wochenschrift 105: 1782–1783 (1975).

    PubMed  CAS  Google Scholar 

  • Oliver, G.C.; Taxman, R. and Frederickson, R.: Influence of congestive heart failure on digoxin level; in Storstein (Ed) Symposium on Digitalis, p.336–347 (Gyldenal Norsk Forlag, Oslo 1974).

    Google Scholar 

  • O’Reilly, R.A. and Aggeler, P.M.: Determinants of the response to oral anticoagulant drugs in man. Pharmacological Reviews 22: 35–96 (1970).

    PubMed  Google Scholar 

  • Piafsky, K.M.; Sitar, D.S.; Rangno, R.E. and Ogilvie, R.I.: Disposition of theophylline in acute pulmonary edema. Clinical Research 22: 726A (1974).

    Google Scholar 

  • Prescott, L.F.: Mechanisms of renal excretion of drugs. British Journal of Anaesthesia 44: 246–251 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Prescott, L.F.: Gastrointestinal absorption of drugs. Medical Clinics of North America 58: 907–916 (1974).

    PubMed  CAS  Google Scholar 

  • Prescott, L.F.; Adjepon-Yomoah, K.K. and Talbot, R.G.: Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. British Medical Journal 1: 939–941 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Reidenberg, M.M.: Renal Function and Drug Action, 113 pp. (Saunders, Philadelphia 1971).

    Google Scholar 

  • Reidenberg, M.M.; Drayer, D.E.; Levy, M. and Warner, H.: Polymorphic acetylation of procainamide in man. Clinical Pharmacology and Therapeutics 17: 722–730 (1975).

    PubMed  CAS  Google Scholar 

  • Ristola, P. and Pyörälä, K.: Determinants of the response to coumarin anticoagulants in patients with acute myocardial infarction. Acta Medica Scandinavica 192: 183–188 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Ritz, R.; Cavanilles, J.; Michaels, S.; Shubin, H. and Weil, M.H.: Disappearance of indocyanine green during circulatory shock. Surgery, Gynecolgy and Obstetrics 136: 57–62 (1973).

    CAS  Google Scholar 

  • Rowland, M.; Benet, L.Z. and Graham, G.G.: Gearance concepts in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1: 123–136 (1973).

    PubMed  CAS  Google Scholar 

  • Stenson, R.E.; Constantino, R.E. and Harrison, D.C.: Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 43: 205–211 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Strong, J.M.; Mayfield, D.E.; Atkinson, A.J., Jr.; Burris, B.C.; Raymon, F. and Webster, L.T., Jr.: Pharmacologic activity, metabolism, and pharmacokinetics of glycinexylidide. Clinical Pharmacology and Therapeutics 17: 184–194 (1975).

    PubMed  CAS  Google Scholar 

  • Svanvik, J.: Mucosal blood circulation and its influence on passive absorption in the small intestine. An experimental study in the cat. Acta Physiologica Scandinavica (Suppl) 385: 1–44 (1973).

    CAS  Google Scholar 

  • Ther, L. and Winne, D.: Drug absorption. Annual Review of Pharmacology 11: 57–70 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Thomson, P.D.; Melmon, K.L.; Richardson, J.A.; Cohn, K.; Steinbrunn, W.; Cudihee, R. and Rowland, M.: Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Annals of Internal Medicine 78: 499–508 (1973).

    PubMed  CAS  Google Scholar 

  • Tilstone, W.J.; Dargie, H.; Dargie, E.N.; Morgan, H.G. and Kennedy, A.C.: Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clinical Pharmacology and Therapeutics 16: 322–329 (1974).

    PubMed  CAS  Google Scholar 

  • Tokola, O.; Pelkonen, O.; Karki, N.T.; Luoma, P.; Kaltiala, E.H. and Larmi, T.K.I.: Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. British Journal of Clinical Pharmacology 2: 429–436 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Tozer, T.N.: Nomogram for modification of dosage regimens in patients with chronic renal function impairment. Journal of Pharmacokinetics and biopharmaceutics 2: 13–28 (1974).

    Google Scholar 

  • Triggs, E.G. and Nation, R.L.: Pharmacokinetics in the aged: A review. Journal of Pharmacokinetics and Biopharmaceutics 3: 387–418 (1975).

    PubMed  CAS  Google Scholar 

  • Ueda, C.T.; Hirschfeld, D.S.; Scheinman, M.M.; Rowland, M.; Williamson, B.J. and Dzindzio, B.S.: Disposition kinetics of quinidine. Clinical Pharmacology and Therapeutics 19: 30–36 (1976).

    PubMed  CAS  Google Scholar 

  • Wagner, J.G.: A safe method for rapidly achieving plasma concentration plateaus. Clinical Pharmacology and Therapeutics 16: 691–700 (1974).

    PubMed  CAS  Google Scholar 

  • Weinberger, M.W.; Matthay, R.A.; Ginchansky, E.J.; Chidsey, C.A. and Petty, T.L.: Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance. Journal of the American Medical Association 235: 2110–2113 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Wilensky, A.J. and Lowden, J.A.: Inadequate serum levels after intramuscular administration of dipheylhydantoin. Neurology 23: 318–324 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson, G.R.: Pharmacokinetics of drug disposition: Hemodynamic considerations. Annual Review of Pharmacology 15: 11–27 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson, G.R. and Schenker, S.: Letter to the Editor: Pharmacokinetics of meperidine in man. Clinical Pharmacology and Therapeutics 19: 486–488 (1976).

    CAS  Google Scholar 

  • Wilkinson, G.R. and Shand, D.G.: Commentary. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).

    PubMed  CAS  Google Scholar 

  • Winne, D.: The influence of villous counter current exchange on intestinal absorption. Journal of Theoretical Biology 53: 145–176 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Winne, D. and Remischovsky, J.: Intestinal blood flow and absorption of non-dissociable substances. Journal of Pharmaceutics and Pharmacology 22: 640–641 (1970).

    Article  CAS  Google Scholar 

  • Zelis, R. and Longhurst, J.: The circulation in congestive heart failure; in Zelis (Ed) The Peripheral Circulations, p. 283–314 (Grune & Stratton, New York 1975).

    Google Scholar 

  • Zito, R.A.; Reid, P.R. and Longstreth, J.A.: Optimization of lidocaine therapy using indocyanine green clearance. Federation Proceedings 35: 222 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Service, Division of Clinical Pharmacology, San Francisco General Hospital, and the Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, California, USA

    Neal L. Benowitz & W. Meister

Authors
  1. Neal L. Benowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Meister
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr Meister is a fellow of the Paul Martini-Stiftung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benowitz, N.L., Meister, W. Pharmacokinetics in Patients with Cardiac Failure. Clin Pharmacokinet 1, 389–405 (1976). https://doi.org/10.2165/00003088-197601060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-197601060-00001

Keywords

Search

Navigation